AZN vs MO · P/E 28, $288.38B cap vs P/E 14, rev $23.28B
AstraZeneca PLC (AZN) versus Altria Group (MO) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Altria Group (MO) is a tobacco company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported MO revenue for 2025-12-31 was $23.28B. Net income was $6.95B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. MO currently screens at market cap $115.14B and trailing P/E 14.4.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. MO currently screens at market cap $115.14B and trailing P/E 14.4.
Not investment advice. Open the AZN and MO stock pages for the full models.
Not investment advice.